Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

  • There is currently no data for BBGI

Acquisition

5 Mar 2020 07:00

RNS Number : 9719E
BBGI SICAV S.A.
05 March 2020
 

5 March 2020

 

 

 

 

BBGI SICAV S.A.

(the "Company")

 

Acquisition of interest in one new availability-based project and a further interest in Stanton Hospital

 

 

BBGI SICAV S.A. (LSE ticker: BBGI), the global infrastructure investment

Company is pleased to announce two recent investment acquisitions.

 

Stanton Hospital

BBGI has completed the acquisition of a further 25% equity interest in the Stanton Territorial Hospital Project ("Stanton"). Stanton is an operational 27,000 m2 hospital with 100 patient rooms located in Yellowknife, Northwest Territories, Canada. The asset is classified as availability-based under the investment policy of the Company. The concession runs until 2048 and availability payments are received from the Government of Northwest Territories, which is rated Aa1 by the credit rating agency Moody's. BBGI's interest in the project is now 50%.

 

The contractual arrangements between the parties require that the exact purchase price be held confidential but can be confirmed to be less than GBP 10 million.

 

Duncan Ball, Co-CEO said: "We are delighted to make a follow-on investment into this important healthcare facility. This acquisition was made on accretive terms and concluded without engaging in an auction process."

 

Highway 104

BBGI, together with its consortium partners, was recently named as the preferred bidder for an availability-based motorway project in Canada that will twin Highway 104 between Sutherlands River and Antigonish in Nova Scotia. Financial close is expected in Q2 2020. Construction is scheduled to begin this spring, with completion expected in 2023. The concession will run until 2043 and availability payments will be received from the Government of Nova Scotia, which is rated Aa2 by Moody's and AA- by Standard & Poor's. BBGI's equity interest in the project will be 50%.

 

 

The cash consideration for both interests in Stanton Hospital and Highway 104 will be funded from the Company's existing cash resources and/or debt facilities.

 

Frank Schramm, Co-CEO said: "We are excited to be involved in the development of this important infrastructure project. The project will improve travel efficiency and safety within Nova Scotia and will create jobs for local workers."

 

For further information, please contact:

BBGI Management Team +352202634791

Duncan Ball

Frank Schramm

 

 

BBGI owns a diversified global portfolio of 48 infrastructure assets spread across seven AAA/AA rated countries. All these projects are availability based assets and are supported by contracted, public sector-backed revenue streams, with inflation-protection characteristics.

 

Further information about BBGI is available on its website at www.bb-gi.com*.

 

The Company's LEI is LEI: 529900CV0RWCOP5YHK95

 

Any reference to the Company or BBGI refers also to its subsidiaries (where applicable).

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on its website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQVZLBBBXLBBBV
Date   Source Headline
6th Nov 201810:20 amRNSHolding(s) in Company
31st Oct 20184:00 pmRNSTotal Voting Rights
25th Oct 20184:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20187:00 amRNSAdditional Listing
12th Oct 20184:37 pmRNSHolding(s) in Company
12th Oct 20187:00 amRNSInclusion in FTSE 250 Index
9th Oct 20186:10 pmRNSSky
1st Oct 20187:53 amRNSTotal Voting Rights
26th Sep 201812:41 pmRNSHolding(s) in Company
26th Sep 201810:56 amRNSHolding(s) in Company
24th Sep 20189:01 amRNSHolding(s) in Company
20th Sep 20182:40 pmRNSHolding(s) in Company
17th Sep 20184:45 pmRNSHolding(s) in Company
17th Sep 20184:02 pmRNSScrip Dividend Circular
14th Sep 20187:00 amRNSResult of Equity Issue
13th Sep 20181:44 pmRNSHolding(s) in Company
11th Sep 20187:00 amRNSProposed Placing
7th Sep 201810:40 amRNSHalf-year Report - Replacement
7th Sep 20189:41 amRNSAnnual Financial Report
31st Aug 20187:00 amRNSInterim Results for six months ended 30 June 2018
30th Aug 20184:45 pmRNSDividend Declaration
29th Aug 20183:37 pmRNSResult of Meeting
1st Aug 20188:24 amRNSDate of Interim Results and Analysts Presentation
31st Jul 20189:42 amRNSHolding(s) in Company
30th Jul 20183:55 pmRNSNotice of GM
19th Jul 201811:16 amRNSDirectorate Change
17th Jul 20188:01 amRNSHolding(s) in Company
17th Jul 20187:00 amRNSAcquisition
2nd Jul 20188:48 amRNSHolding(s) in Company
29th Jun 20185:12 pmRNSTotal Voting Rights
29th Jun 20182:13 pmRNSDirectorate Change
29th Jun 20182:02 pmRNSResult of Meeting
29th Jun 20187:00 amRNSAcquisition
28th Jun 20185:31 pmRNSHolding(s) in Company
27th Jun 201810:58 amRNSHolding(s) in Company
21st Jun 20185:46 pmRNSHolding(s) in Company
8th Jun 201811:23 amRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSAdditional Listing
30th May 20184:30 pmRNSGM Convening Notice and Proxy Form
23rd May 20188:04 amRNSNotification of Major Holdings
1st May 20187:00 amRNSTotal Voting Rights Update
30th Apr 20184:30 pmRNSScrip Dividend Circular
30th Apr 20183:23 pmRNSResults of Annual General Meeting
26th Apr 20183:31 pmRNSNotification of Major Holdings
19th Apr 20187:00 amRNSResult of Equity Issue
18th Apr 201810:37 amRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSProposed Placing
16th Apr 20184:21 pmRNSAdditional Listing
16th Apr 20187:25 amRNSAcquisition of further interest
11th Apr 20189:47 amRNSAnnual Financial Report 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.